CYP3A mediated drug-drug interactions: Contribution of CYP 3A4 and CYP 3A5

被引：0
|
作者：
Patki, KC [1 ]
von Moltke, LL [1 ]
Greenblatt, DJ [1 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2002年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
29
引用
收藏
页码：1057 / 1057
页数：1
相关论文
共 50 条
  • [1] CYP3A and drug interactions
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1212): : 54 - 55
  • [2] QUANTITATIVE PREDICTION OF CYP3A4 AND CYP3A5-MEDIATED DRUG DRUG INTERACTIONS
    Guo, Yingying
    Lucksiri, Aroonrut
    Dickinson, Gemma
    Vuppalanchi, Raj
    Hilligoss, Janna
    Huang, Shiew-Mei
    Hall, Stephen
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S43 - S44
  • [3] Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
    Shirasaka, Yoshiyuki
    Chang, Shu-Ying
    Grubb, Mary F.
    Peng, Chi-Chi
    Thummel, Kenneth E.
    Isoherranen, Nina
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (08) : 1566 - 1574
  • [4] IMPACT OF CYP3A5 EXPRESSION ON THE INHIBITION OF CYP3A-CATALYZED DRUG METABOLISM: CONSIDERATIONS FOR MODELING CYP3A-MEDIATED DRUG-DRUG INTERACTIONS
    Shirasaka, Yoshiyuki
    Peng, Chi-Chi
    Chang, Shu-Ying
    Grubb, Mary F.
    Johnson, Stephen R.
    Rodrigues, A. David
    Thummel, Kenneth E.
    Isoherranen, Nina
    DRUG METABOLISM REVIEWS, 2012, 44 : 83 - 84
  • [5] MDR- and CYP3A4-Mediated Drug-Drug Interactions
    Pal, Dhananjay
    Mitra, Ashim K.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (03) : 323 - 339
  • [6] Quantitative Prediction of CYP3A4-and CYP3A5-Mediated Drug Interactions
    Guo, Yingying
    Lucksiri, Aroonrut
    Dickinson, Gemma L.
    Vuppalanchi, Raj K.
    Hilligoss, Janna K.
    Hall, Stephen D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (01) : 246 - 256
  • [7] Quantitative prediction of CYP3A induction-mediated drug-drug interactions in clinical practice
    Tsutsui, Haruka
    Kato, Motohiro
    Kuramoto, Shino
    Yoshinari, Kouichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2024, 57
  • [8] Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of CYP3A
    Yadav, Jaydeep
    Korzekwa, Ken
    Nagar, Swati
    MOLECULAR PHARMACEUTICS, 2018, 15 (05) : 1979 - 1995
  • [9] PREDICTION OF CYP3A MEDIATED DRUG-DRUG INTERACTIONS: ESTIMATION OF GUT WALL AND HEPATIC CONTRIBUTIONS
    Han, B.
    Dickinson, G. L.
    Turner, P. K.
    Hall, S. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S44 - S45
  • [10] Utility of transgenic mouse models to assess magnitude of CYP3A mediated drug-drug interactions
    Ly, Justin Q.
    Messick, Kirsten
    Qin, Ann Ran-Ran
    Choo, Edna F.
    DRUG METABOLISM REVIEWS, 2016, 48 : 44 - 45
12345